It’s available as a cartridge that’s attached to a reusable pen and ... purplebooksearch.fda.gov Genotropin (somatropin) for injection, for subcutaneous use. (2019). https://labeling.pfizer ...

Pfizer disclosed ... a pre-filled injection pen. In Phase 3 testing in children, somatrogon met the main goal of showing that it was not inferior to daily injections of Genotropin as assessed ...

Pfizer Inc. agreed to pay $34.7 million in fines to settle Justice Department allegations that it improperly promoted the human growth hormone product Genotropin. The drug maker’s Pharmacia ...

Genotropin generated revenues of $772 million in 2013. Pfizer carries a Zacks Rank #3 (Hold). Pfizer will be hit by a series of patent expiries including that of Aricept, Revatio and Viagra until ...

A billion dollar market opportunity Pfizer's Genotropin is one of the most widely-used human growth therapies, but a host of other companies, including market-share leader Novo Nordisk ...

Pfizer announced top-line results from its Phase 3B study evaluating the 24-month efficacy of Genotropin (somatropin) on the height in small-for-gestational-age (SGA) children 24–30 months old.

SCOTT JAGOW: Pfizer has agreed to pay almost $35 million to settle an investigation by the Justice Department. Feds were looking into how a drug called Genotropin was promoted. It’s a human ...

A phase 3 trial has found Pfizer and Opko Health’s once-weekly growth hormone deficiency (GHD) treatment imposes less of a burden than the established daily drug Genotropin. The readout comes ...

In a bid to protect sales for its human growth hormone drug Genotropin, Pfizer licensed rights to a longer-lasting human growth hormone therapy, hGH-CTP, in December. This longer-lasting drug has ...